van der Zwaan G Lennart, van Dijk Susan E M, Adriaanse Marcel C, van Marwijk Harm W J, van Tulder Maurits W, Pols Alide D, Bosmans Judith E
Department of Health Sciences and the EMGO Institute for Health and Care Research, Faculty of Earth and Life Sciences, VU University Amsterdam, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.
Department of General Practice and Elderly Care Medicine the EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands.
J Affect Disord. 2016 Jan 15;190:68-74. doi: 10.1016/j.jad.2015.09.045. Epub 2015 Oct 9.
Depression is common among type 2 diabetes mellitus (DM2)/coronary heart disease (CHD) patients and is associated with adverse health effects. A promising strategy to reduce burden of disease is to identify patients at risk for depression in order to offer indicated prevention. This study aims to assess the diagnostic accuracy of the Patient Health Questionnaire-9 (PHQ-9) to be used as a tool to identify high risk patients.
In this cross-sectional study, 586 consecutive DM2/CHD patients aged >18 were recruited through 23 general practices. PHQ-9 outcomes were compared to the Mini International Neuropsychiatric Interview (MINI), which was considered the reference standard. Diagnostic accuracy was evaluated for minor and major depression, comparing both sum- and algorithm based PHQ-9 scores.
For minor depression, the optimal cut-off score was 8 (sensitivity 71%, specificity 71% and an AUC of 0.74). For major depression, the optimal cut-off score was 10 resulting in a sensitivity of 84%, a specificity of 82%, and an AUC of 0.88. The positive predictive value of the PHQ-9 algorithm for diagnosing minor and major depression was 25% and 33%, respectively.
Two main limitations apply. MINI Interviewers were not blinded for PHQ-9 scores and less than 10% of all invited patients could be included in the analyses. This could have resulted in biased outcomes.
The PHQ-9 sum score performs well in identifying patients at high risk of minor and major depression. However, the PHQ-9 showed suboptimal results for diagnostic purposes. Therefore, it is recommended to combine the use of the PHQ-9 with further diagnostics to identify depression.
抑郁症在2型糖尿病(DM2)/冠心病(CHD)患者中很常见,且与不良健康影响相关。减轻疾病负担的一个有前景的策略是识别有抑郁症风险的患者,以便进行有针对性的预防。本研究旨在评估患者健康问卷-9(PHQ-9)作为识别高危患者工具的诊断准确性。
在这项横断面研究中,通过23家普通诊所招募了586名年龄大于18岁的连续DM2/CHD患者。将PHQ-9的结果与被视为参考标准的迷你国际神经精神访谈(MINI)进行比较。针对轻度和重度抑郁症评估诊断准确性,比较基于总分和算法的PHQ-9评分。
对于轻度抑郁症,最佳临界值为8(敏感性71%,特异性71%,曲线下面积0.74)。对于重度抑郁症,最佳临界值为10,敏感性为84%,特异性为82%,曲线下面积为0.88。PHQ-9算法诊断轻度和重度抑郁症的阳性预测值分别为25%和33%。
存在两个主要局限性。MINI访谈者未对PHQ-9评分设盲,且所有受邀患者中不到10%可纳入分析。这可能导致结果有偏差。
PHQ-9总分在识别轻度和重度抑郁症高危患者方面表现良好。然而,PHQ-9在诊断方面显示出不理想的结果。因此,建议将PHQ-9的使用与进一步诊断相结合以识别抑郁症。